- 11 February 2013
First Target magazines of 2013 now online We're pleased to bring you the first edition of Target MD and Target Research for 2013, the charity's flagship quarterly publications. - 8 February 2013
Engaging with commissioners to improve neuromuscular services in Yorkshire and Humber Yesterday we held the first of our ‘patient panel’ meetings in York, bringing together patient representatives from across Yorkshire and new NHS commissioners - 8 February 2013
Study of long-term steroid use in boys with Duchenne muscular dystrophy A group of researchers led by Prof. Francesco Muntoni has published the results of a study into long-term steroid use in boys with Duchenne muscular dystrophy. - 7 February 2013
Supporting cross-party parliamentary action across the UK The Muscular Dystrophy Campaign continues to lead the fight for better access to neuromuscular services alongside our parliamentary supporters. - 1 February 2013
Campaign victory secured on PIP regulations Baroness Thomas of Winchester, a Muscular Dystrophy Campaign Trustee, has secured a major victory for patients with muscle wasting condition concerned about new Personal Independence Payments (PIP) regulations. - 31 January 2013
New report reveals significant gaps in specialist care and support Significant gaps in specialist care and support and GPs' lack of understanding of muscle-wasting conditions has been revealed in our patients' report State of the Nation. - 31 January 2013
Prosensa awarded orphan drug status Prosensa has received orphan drug status for further molecular patches both in Europe and the USA. - 30 January 2013
'PIP's Good to Talk' - your questions answered The advocacy team held their first ever Facebook Q&A session on Wednesday to answer your questions about new benefits system. - 28 January 2013
Dave Anderson MP - fighting for access to treatment Dave Anderson MP, Chair of the All Party Parliamentary Group for Muscular Dystrophy, is leading the fight for access to potential treatments for people with muscle-wasting conditions. - 27 January 2013
Mutations which cause FSH type 2 identified An international team of researchers from the Netherlands, France and the USA has identified mutations in a gene called SMCHD1 which can cause FSH type 2
